Methylation-mediated repression of GADD45alpha in prostate cancer and its role as a potential therapeutic target. [electronic resource]
Producer: 20090324Description: 1527-35 p. digitalISSN:- 1538-7445
- Antineoplastic Agents -- therapeutic use
- Azacitidine -- therapeutic use
- Cell Cycle Proteins -- antagonists & inhibitors
- Cell Line, Tumor
- DNA Methylation
- DNA Primers
- DNA, Neoplasm -- genetics
- Docetaxel
- Gene Expression Regulation, Neoplastic
- Genome
- Humans
- Male
- Methylation
- Nuclear Proteins -- antagonists & inhibitors
- Prostatic Neoplasms -- drug therapy
- Reverse Transcriptase Polymerase Chain Reaction
- Taxoids -- therapeutic use
- Up-Regulation
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
There are no comments on this title.
Log in to your account to post a comment.